Company profile

TOLREMO therapeutics AG

There is a high unmet need for durable therapeutic options for cancer patients. Although cancer drugs relief patients from their tumor burden, they oftentimes lose their effectiveness over time. TOLREMO develops novel small molecules that eradicate drug resistant cancer cells right at the start of a therapy. TOLREMO’s resistance-breaking add-on therapies can be combined with existing cancer drugs, to meaningfully extend the lives of patients suffering from different types of cancer.MAKING CANCER A MINOR MATTER

More news about TOLREMO therapeutics AG

28.03.2024 09:00

New additions to startups’ board of directors

Please login or
register to use the
awards follow feature
30.11.2023 15:00

TOLREMO doses first patient in Phase 1 clinical trial

Please login or
register to use the
awards follow feature
21.11.2023 16:00

SEF.WomenAward reveals the finalists

Please login or
register to use the
awards follow feature
20.09.2023 11:29

TOLREMO therapeutics Completes USD 39 Million Series A Financing Round

Please login or
register to use the
awards follow feature
08.07.2022 15:30

Tolremo’s founder Stefanie Flückiger-Mangual is the Innovator of the Year

Please login or
register to use the
awards follow feature
13.06.2022 15:30

Female Innovation Forum: six startups nominated for two awards

Please login or
register to use the
awards follow feature
13.11.2020 11:26

Das sind die Finalisten des Swiss Technology Award 2020

Please login or
register to use the
awards follow feature
02.11.2020 15:03

Three Swiss projects contest for the EIT Awards 2020

Please login or
register to use the
awards follow feature
03.08.2020 11:18

Female entrepreneurs in the spotlight

Please login or
register to use the
awards follow feature
10.06.2020 11:00

Additional capital for TOLREMO therapeutics

Please login or
register to use the
awards follow feature
21.01.2020 16:05

BaseLaunch accelerator nominates 4 startups for phase 2

Please login or
register to use the
awards follow feature
08.01.2020 11:51

ZKB Pionierpreis Technopark: Zehn Firmen kämpfen um 100‘000 Franken

Please login or
register to use the
awards follow feature
02.12.2019 09:17

Tolremo gewinnt Swiss Innovation Challenge 2019

Please login or
register to use the
awards follow feature
04.10.2019 12:05

A new cohort joins the BaseLaunch accelerator

Please login or
register to use the
awards follow feature
15.05.2019 10:15

>>Venture>> finalists to contest for a cash prize of CHF 350000

Please login or
register to use the
awards follow feature
01.04.2019 16:45

Swiss Biotech Day to shed light on 13 emerging startups

Please login or
register to use the
awards follow feature
27.03.2019 09:35

10 Winners of Venture Leaders Life Sciences Selected

Please login or
register to use the
awards follow feature
24.09.2018 11:04

TOLREMO raises CHF9 million series A financing round

Please login or
register to use the
awards follow feature
19.09.2017 09:38

Biotech start-up TOLREMO closes CHF2,4 million financing round

Please login or
register to use the
awards follow feature
TOLREMO therapeutics AG

Founded
2017

Kanton
Basel-Stadt


LinkedIn

Twitter
@TOLREMO

Homepage

rss